{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T01:54:42Z","timestamp":1774922082124,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>In the European Union, medicines are authorised for some rare disease only if they are judged to be dissimilar to authorised orphan drugs for that disease. This paper describes the use of 2D fingerprints to show the extent of the relationship between computed levels of structural similarity for pairs of molecules and expert judgments of the similarities of those pairs. The resulting relationship can be used to provide input to the assessment of new active compounds for which orphan drug authorisation is being sought.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>143 experts provided judgments of the similarity or dissimilarity of 100 pairs of drug-like molecules from the DrugBank 3.0 database. The similarities of these pairs were also computed using BCI, Daylight, ECFC4, ECFP4, MDL and Unity 2D fingerprints. Logistic regression analyses demonstrated a strong relationship between the human and computed similarity assessments, with the resulting regression models having significant predictive power in experiments using data from submissions of orphan drug medicines to the European Medicines Agency. The BCI fingerprints performed best overall on the DrugBank dataset while the BCI, Daylight, ECFP4 and Unity fingerprints performed comparably on the European Medicines Agency dataset.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Measures of structural similarity based on 2D fingerprints can provide a useful source of information for the assessment of orphan drug status by regulatory authorities.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1758-2946-6-5","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T08:01:23Z","timestamp":1391241683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation"],"prefix":"10.1186","volume":"6","author":[{"given":"Pedro","family":"Franco","sequence":"first","affiliation":[]},{"given":"Nuria","family":"Porta","sequence":"additional","affiliation":[]},{"given":"John D","family":"Holliday","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Willett","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,2,1]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.healthpol.2010.12.002","volume":"100","author":"S Morgan","year":"2011","unstructured":"Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D: The cost of drug development: a systematic review. Health Policy. 2011, 100: 4-17. 10.1016\/j.healthpol.2010.12.002.","journal-title":"Health Policy"},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.drudis.2012.02.005","volume":"17","author":"KN Meekings","year":"2012","unstructured":"Meekings KN, Williams CSM, Arrowsmith JE: Orphan drug development: an economically viable strategy for biopharma R&D. Drug Discov Today. 2012, 17: 660-664. 10.1016\/j.drudis.2012.02.005.","journal-title":"Drug Discov Today"},{"key":"494_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrd3654","volume":"11","author":"I Melnikova","year":"2012","unstructured":"Melnikova I: Rare diseases and orphan drugs. Nat Rev Drug Discov. 2012, 11: 267-268. 10.1038\/nrd3654.","journal-title":"Nat Rev Drug Discov"},{"key":"494_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nrd3275","volume":"9","author":"E Tambuyzer","year":"2010","unstructured":"Tambuyzer E: Rare diseases, orphan drugs and their regulation: questions and misconceptions. Nat Rev Drug Discov. 2010, 9: 921-928. 10.1038\/nrd3275.","journal-title":"Nat Rev Drug Discov"},{"key":"494_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrd3445","volume":"10","author":"K Westermark","year":"2011","unstructured":"Westermark K, Holm BB, S\u00f6derholm M, Llinares-Garcia J, Rivi\u00e8re F, Aarum S, Butlen-Ducuing F, Tsigkos S, Wilk-Kachlicka A, N\u2019Diamoi C, Borvend\u00e9g J, Lyons D, Sepodes B, Bloechl-Daum B, Lhoir A, Todorova M, Kkolos I, Kub\u00e1\u010dkov\u00e1 K, Bosch-Traberg H, Tillmann V, Saano V, H\u00e9ron E, Elbers R, Siouti M, Eggenhofer J, Salmon P, Clementi M, Krievi\u0146\u0161 D, Matulevi\u010diene A, Metz H, et al: European regulation on orphan medicinal products: 10\u00a0years of experience and future perspectives. Nat Rev Drug Discov. 2011, 10: 341-349.","journal-title":"Nat Rev Drug Discov"},{"key":"494_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.drudis.2011.12.014","volume":"17","author":"D Lev","year":"2012","unstructured":"Lev D, Thorat C, Phillips I, Thomas M, Imoisili MA: The routes to orphan drug designation - our recent experience at the FDA. Drug Discov Today. 2012, 17: 97-99. 10.1016\/j.drudis.2011.12.014.","journal-title":"Drug Discov Today"},{"key":"494_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drudis.2012.08.009","volume":"18","author":"P Franco","year":"2013","unstructured":"Franco P: Orphan drugs: the regulatory environment. Drug Discov Today. 2013, 18: 163-172. 10.1016\/j.drudis.2012.08.009.","journal-title":"Drug Discov Today"},{"key":"494_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.cognition.2008.07.003","volume":"108","author":"S Simmons","year":"2008","unstructured":"Simmons S, Estes Z: Individual differences in the perception of similarity and difference. Cognition. 2008, 108: 781-795. 10.1016\/j.cognition.2008.07.003.","journal-title":"Cognition"},{"key":"494_CR9","doi-asserted-by":"publisher","first-page":"e48476","DOI":"10.1371\/journal.pone.0048476","volume":"7","author":"PS Kutchukian","year":"2012","unstructured":"Kutchukian PS, Vasilyeva NY, Xu J, Lindvall MK, Dillon MP, Glick M, Coley JD, Brooijmans N: Inside the mind of a medicinal chemist: the role of human bias in compound prioritization during drug discovery. PLOS One. 2012, 7: e48476-10.1371\/journal.pone.0048476.","journal-title":"PLOS One"},{"key":"494_CR10","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1021\/jm049740z","volume":"47","author":"M Lajiness","year":"2004","unstructured":"Lajiness M, Maggiora G, Shanmugasundaram V: Assessment of the consistency of medicinal chemists in reviewing sets of compounds. J Med Chem. 2004, 47: 4891-4896. 10.1021\/jm049740z.","journal-title":"J Med Chem"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1021\/ci200446y","volume":"51","author":"MD Hack","year":"2011","unstructured":"Hack MD, Rassokhin DN, Buyck C, Seierstad M, Skalkin A, ten Holte P, Jones TK, Mirzadegan T, Agrafiotis DK: Library enhancement through the wisdom of crowds. J Chem Inf Model. 2011, 51: 3275-3286. 10.1021\/ci200446y.","journal-title":"J Chem Inf Model"},{"key":"494_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nchembio0709-441","volume":"5","author":"TI Oprea","year":"2009","unstructured":"Oprea TI, Bologa CG, Boyer S, Curpan RF, Glen RC, Hopkins AL, Lipinski CA, Marshall GR, Martin YC, Ostopovici-Halip L, et al: A crowdsourcing evaluation of the NIH chemical probes. Nature Chemical Biology. 2009, 5: 441-447. 10.1038\/nchembio0709-441.","journal-title":"Nature Chemical Biology"},{"key":"494_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10822-006-9099-2","volume":"21","author":"K Boda","year":"2007","unstructured":"Boda K, Seidel T, Gasteiger J: Structure and reaction based evaluation of synthetic accessibility. J Comput Aided Mol Des. 2007, 21: 311-325. 10.1007\/s10822-006-9099-2.","journal-title":"J Comput Aided Mol Des"},{"key":"494_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ejmech.2012.06.024","volume":"54","author":"P Bonnet","year":"2012","unstructured":"Bonnet P: Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists. Eur J Med Chem. 2012, 54: 679-689.","journal-title":"Eur J Med Chem"},{"key":"494_CR15","first-page":"155","volume":"6","author":"K Markey","year":"1984","unstructured":"Markey K: Inter-indexer consistency tests. Libr Inf Sci Res. 1984, 6: 155-177.","journal-title":"Libr Inf Sci Res"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1108\/eb026925","volume":"50","author":"D Ellis","year":"1994","unstructured":"Ellis D, Furner-Hines J, Willett P: On the creation of hypertext links in full-text documents: measurement of inter-linker consistency. J Doc. 1994, 50: 67-98. 10.1108\/eb026925.","journal-title":"J Doc"},{"key":"494_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0306-4573(95)80034-Q","volume":"31","author":"M Iivonen","year":"1995","unstructured":"Iivonen M: Consistency in the selection of search concepts and search terms. Inf Process Manage. 1995, 31: 173-190. 10.1016\/0306-4573(95)80034-Q.","journal-title":"Inf Process Manage"},{"key":"494_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF02016288","volume":"28","author":"RJW Tijssen","year":"1993","unstructured":"Tijssen RJW: A scientometric cognitive study of neural network research: expert mental maps versus bibliometric maps. Scientometrics. 1993, 28: 111-136. 10.1007\/BF02016288.","journal-title":"Scientometrics"},{"key":"494_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/ci60001a016","volume":"15","author":"GW Adamson","year":"1975","unstructured":"Adamson GW, Bush JA: A comparison of the performance of some similarity and dissimilarity measures in the automatic classification of chemical structures. J Chem Inf Comput Sci. 1975, 15: 55-58. 10.1021\/ci60001a016.","journal-title":"J Chem Inf Comput Sci"},{"key":"494_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.drudis.2011.02.011","volume":"16","author":"P Ripphausen","year":"2011","unstructured":"Ripphausen P, Nisius B, Bajorath J: State-of-the-art in ligand-based virtual screening. Drug Discov Today. 2011, 16: 372-376. 10.1016\/j.drudis.2011.02.011.","journal-title":"Drug Discov Today"},{"key":"494_CR21","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1021\/ci300261r","volume":"52","author":"R Todeschini","year":"2012","unstructured":"Todeschini R, Consonni V, Xiang H, Holliday JD, Buscema M, Willett P: Similarity coefficients for binary chemoinformatics data: overview and extended comparison using simulated and real datasets. J Chem Inf Model. 2012, 52: 2884-2901. 10.1021\/ci300261r.","journal-title":"J Chem Inf Model"},{"key":"494_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ci300547g","volume":"53","author":"P Willett","year":"2013","unstructured":"Willett P: Combination of similarity rankings using data fusion. J Chem Inf Model. 2013, 53: 1-10. 10.1021\/ci300547g.","journal-title":"J Chem Inf Model"},{"key":"494_CR23","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.1016\/j.bmc.2010.08.026","volume":"18","author":"PW Manley","year":"2010","unstructured":"Manley PW, Stiefl N, Cowan-Jacob SW, Kaufman S, Mestan J, Wartmann M, Wiesmann M, Woodman R, Gallagher N: Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib. Bioorg Med Chem. 2010, 18: 6977-6986. 10.1016\/j.bmc.2010.08.026.","journal-title":"Bioorg Med Chem"},{"key":"494_CR24","doi-asserted-by":"publisher","first-page":"D1035","DOI":"10.1093\/nar\/gkq1126","volume":"39","author":"C Knox","year":"2011","unstructured":"Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al: DrugBank 3.0: a comprehensive resource for \u2018omics\u2019 research on drugs. Nucleic Acids Res. 2011, 39: D1035-D1041. 10.1093\/nar\/gkq1126.","journal-title":"Nucleic Acids Res"},{"key":"494_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M: Extended-connectivity fingerprints. J Chem Inf Model. 2010, 50: 742-754. 10.1021\/ci100050t.","journal-title":"J Chem Inf Model"},{"key":"494_CR26","first-page":"3","volume":"43","author":"P Willett","year":"2009","unstructured":"Willett P: Similarity methods in chemoinformatics. Ann Rev Inf Sci Technol. 2009, 43: 3-71.","journal-title":"Ann Rev Inf Sci Technol"},{"key":"494_CR27","first-page":"260","volume":"1","author":"D Stumpfe","year":"2011","unstructured":"Stumpfe D, Bajorath J: Similarity searching. Wiley Interdiscip Rev: Comput Mol Sci. 2011, 1: 260-282. 10.1002\/wcms.23.","journal-title":"Wiley Interdiscip Rev: Comput Mol Sci"},{"key":"494_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/sam.10037","volume":"2","author":"EJ Gardiner","year":"2009","unstructured":"Gardiner EJ, Gillet VJ, Haranczyk M, Hert J, Holliday JD, Malim N, Patel Y, Willett P: Turbo similarity searching: effect of fingerprint and dataset on virtual-screening performance. Stat Anal Data Min. 2009, 2: 103-114. 10.1002\/sam.10037.","journal-title":"Stat Anal Data Min"},{"key":"494_CR29","first-page":"121","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models. A framework for traditional and novel measures. Epidemiology. 2010, 21: 121-138.","journal-title":"Epidemiology"},{"key":"494_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A: Beware of q2!. J Mol Graph Model. 2002, 20: 269-276. 10.1016\/S1093-3263(01)00123-1.","journal-title":"J Mol Graph Model"},{"key":"494_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P: Principles of QSAR models validation: internal and external. QSAR & Combinatorial Science. 2007, 26: 694-701. 10.1002\/qsar.200610151.","journal-title":"QSAR & Combinatorial Science"}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1758-2946-6-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-6-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1758-2946-6-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:54:23Z","timestamp":1630551263000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/1758-2946-6-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1186\/1758-2946-6-5","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,1]]},"assertion":[{"value":"28 October 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}